Product Information
CYCLOBENZAPRINE 5 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.0211 per EA under NDC 43547039950. Its NADAC has been published 472 times since Jun 14, 2017.
Strength
5 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547039950
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CYCLOBENZAPRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077797On Market Since
3/30/2017
Pharmacological Classes
Price Statistics
The NADAC for CYCLOBENZAPRINE 5 MG TABLET has been published 472 times since Jun 14, 2017, and over the history we have for it it has declined 50.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0211 per EA |
|---|---|
| All-time high | $0.0453 (Oct 11, 2017) |
| All-time low | $0.0157 (Nov 20, 2024) |
| 52-week high | $0.0220 |
| 52-week low | $0.0209 |
| Median price | $0.0301 |
| Average price | $0.0289 |
| Largest weekly change | +36.3% (Aug 21, 2024) |
| Weeks tracked | 472 |
| Tracking since | Jun 14, 2017 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CYCLOBENZAPRINE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE 5 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.0211 per EA (NDC 43547039950), effective Jun 24, 2026.
How has the price of CYCLOBENZAPRINE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CYCLOBENZAPRINE 5 MG TABLET has declined 50.0%. It has been tracked across 472 weekly CMS publications since Jun 14, 2017.
What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE 5 MG TABLET?
Since Jun 14, 2017, the NADAC for CYCLOBENZAPRINE 5 MG TABLET has ranged from a low of $0.0157 (Nov 20, 2024) to a high of $0.0453 (Oct 11, 2017), with a median of $0.0301 per EA.
Are there cheaper alternatives to CYCLOBENZAPRINE 5 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as CYCLOBENZAPRINE 5 MG TABLET, but none are currently priced below it.
Who manufactures CYCLOBENZAPRINE 5 MG TABLET?
CYCLOBENZAPRINE 5 MG TABLET (NDC 43547039950) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification